Tudor Investment Corp’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Sell	89,223 -99,853	-53%	-$1.27M	0.01%	2268
2025 Q4	$1.7M	Buy	+189,076	New	+$2.6M	0.01%	1923
2025 Q3	–	Sell	-114,964	Closed	-$1.08M	–	3952
2025 Q2	$1.08M	Buy	114,964 +46,687	+68%	+$383K	0.01%	2080
2025 Q1	$485K	Buy	+68,277	New	+$690K	﹤0.01%	2302
2024 Q4	–	Sell	-24,803	Closed	-$387K	–	3531
2024 Q3	$510K	Sell	24,803 -36,980	-60%	-$853K	0.01%	2024
2024 Q2	$1.38M	Buy	61,783 +14,308	+30%	+$341K	0.02%	1285
2024 Q1	$1.31M	Buy	+47,475	New	+$1.32M	0.02%	1214
2023 Q4	–	Sell	-7,638	Closed	-$242K	–	2819
2023 Q3	$242K	Buy	+7,638	New	+$296K	﹤0.01%	2017
2023 Q1	–	Sell	-44,902	Closed	-$1.57M	–	2889
2022 Q4	$1.57M	Buy	44,902 +13,817	+44%	+$657K	0.04%	787
2022 Q3	$1.74M	Buy	+31,085	New	+$1.93M	0.04%	599
2022 Q2	–	Sell	-19,273	Closed	-$1.4M	–	2468
2022 Q1	$1.4M	Buy	+19,273	New	+$1.63M	0.04%	731
2021 Q4	–	Sell	-12,109	Closed	-$1.62M	–	2911
2021 Q3	$1.62M	Buy	12,109 +4,654	+62%	+$705K	0.03%	839
2021 Q2	$1.21M	Buy	+7,455	New	+$581K	0.02%	777